BK · a US exchange · USD · Market cap $94.1B · 47,200 employees
The Bank of New York Mellon Corporation provides a range of financial products and services in the United States and internationally.
FAIL · Does not pass the screen
137.16 USD
At the last full screen 2026-07-19
Screened 2026-07-19 · the tape above runs as of 22:12 UTC · 11 Sep · two dates, stated on purpose · verdict and workings shown in full · never trimmed
The Label · The Season, Not the Day
This name holds its accumulation label.
BNY Mellon holds its Accumulation at $137.16. The statistical read favours the buyers, held for 2 days.
As held on the ledger · 2026-07-19
Phase
Accumulation
Quantitative state
The statistical read favours the buyers, held for 2 days
Price at the screen
$137.16
Valuation
17.02 trailing · 14.23 forward price to earnings
Values screen
FAIL· score 10.0
Beta
1.07
The Workings
Five Screens, Shown in Full
Does not pass. Business activity screen
Test
Figure
Limit
What it means
Status
Business activity
Excluded
Core business clean
Business activity: Financials sector
Fail
Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.
What the Numbers Say It Is Worth
The Fair Value Range
Our framework reads AVOID: it trades at roughly a 5% discount to our $144.57 fair value, moderate competitive moat, 13.40% revenue growth.
Fair value range in USD, drawn from the 2026-07-19 screen. The gold marker is the market price at the same screen. A 5.4% margin of safety to the base estimate.
Third-party analyst targets: 14 covering, consensus Buy. The average target sits +5% from the screen price.
Reading the gap · Both our model and the analysts see meaningful upside from here.
Price History & Projections
Where it has been, where the models see it going. History from market close data; projection points are our fair-value estimates and third-party analyst targets, dated to the 2026-07-19 screen.
Fair value and rating are our own model estimates; the Street's range reflects third-party analyst estimates. Analysis, not advice.
The Business, in Plain Words
Trusted Custodian Bank Still Fails Our Screen
Picture a quiet back office moving trillions in assets for pension funds and asset managers every day. BNY Mellon sits at the centre of that plumbing yet we pass because it fails the business activity screen outright. The ethical red flag overrides everything else on the table.
Revenue is growing 13 percent with a 29 percent profit margin and 13 percent return on equity at a forward multiple of 14.2 times. Our fair value sits only 5 percent above the current price so the numbers look steady rather than exciting. Moderate moat and a buy-rated analyst target around 144 add little when the screen already says no.
Cyclical banking exposure plus the ethical block keep risk elevated even if earnings hold up. We see no reason to stretch the mandate here.
The risks · The main risks here are ordinary market swings and the chance our fair-value read proves too optimistic.
Plain-English interpretation of our own screen data. Analysis, not advice.
Where & How to Trade
BK trades on a US exchange. As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.
The Dated Journal · Newest First, Never Edited
Every Entry, As Written
2026-08-23Accumulation$137.16+0.0%Entry 6
The framework reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it A, carrying a low risk profile. Technically it is holding around 22% above its long-term trend line with momentum reading overbought. Over the past year the shares are up 62%. Our forward projection puts the odds of a 10% gain over the next month near 29%. The street (14 analysts) rates it buy, with a mean price target of $143.
2026-07-23Accumulation$137.16-3.7%Entry 5
The framework reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 3.7% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it A, carrying a low risk profile. Technically it is holding around 22% above its long-term trend line with momentum reading overbought. Over the past year the shares are up 62%. Our forward projection puts the odds of a 10% gain over the next month near 29%. The street (14 analysts) rates it buy, with a mean price target of $143.
2026-07-18Accumulation$142.39+0.0%Entry 4
The framework reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it A, carrying a low risk profile. Technically it is holding around 22% above its long-term trend line with momentum reading overbought. Over the past year the shares are up 62%. Our forward projection puts the odds of a 10% gain over the next month near 29%. The street (14 analysts) rates it buy, with a mean price target of $143.
2026-07-15Accumulation$142.39+0.0%Entry 3
The framework reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. It reported earnings in this window, a natural checkpoint for the thesis.
2026-07-03Accumulation$142.39+0.0%Entry 2
The framework reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns.
2026-07-02Accumulation$142.39Entry 1
The framework reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.